Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism

NCT03364738 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to Takeda commercial Natpara recall.

Conditions

Interventions

Sponsor

Shire